Movement disorders comprise a large group of often progressive conditions characterized by abnormalities in motor control, including Parkinson’s disease, dystonia, tremor, myoclonus, chorea, and tics. The Bonnie and Tom Strauss Movement Disorders Center at the Icahn School of Medicine at Mount Sinai is focused on transforming the conventional research and care paradigm for movement disorders by aiming for precision cures and prevention. The Strauss Center is now the dynamic hub of translational research and clinical treatment for movement disorders within the Mount Sinai Health System.
The Strauss Center leverages Mount Sinai’s deep bench in research in neurology, genetics, neuroscience, bioinformatics and analytics, and related fields, expediting the pace of discovery. The Center also has the advantage of a large and varied patient population and a large team of outstanding clinical and research experts to integrate the research and genomics platform into daily care for all our patients—a truly advanced translational model. This integrated approach facilitates the creation of the next generation of treatments and eventual cures. Its hallmark will be true precision medicine—coordinated, compassionate, and collegial care that treats each patient as an individual.
Using patient-derived data to customize care, our Center’s physicians and researchers are revolutionizing the diagnosis, treatment, and study of movement disorders, working daily toward the ultimate goals of finding a cure and preventing disease. Our mission is to evaluate and treat each patient comprehensively and compassionately, applying state-of-the-art tools. Our broad and dynamic research program brings precision medicine to the movement disorders community, using biological and other markers to refine diagnosis and treatment. Our vision is recognized internationally as the premier center for the diagnosis and treatment of movement disorders and the translation of research and technologic advances to precision clinical practice.